Han Biomedical

Han Biomedical FCF per Share

The Free Cash Flow per Share of Han Biomedical (6999.TWO) as of Oct 10, 2026 is 1.41 TWD. In the previous year, Free Cash Flow per Share was 1.40 TWD — a change of 0.77% (higher).

FCF per Share

1.41TWD

YoY

0.77%

Last updated:

Free Cash Flow per Share of Han Biomedical is 2024 1.41 TWD. Free Cash Flow per Share of Han Biomedical was 2023 1.40 TWD. It decreases by 0.77% higher compared to the previous year.

The Han Biomedical FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2022
1.05 TWD
Jan 1, 2023
1.40 TWD
Jan 1, 2024
1.41 TWD
The Han Biomedical FCF per Share history
YEARFCF per ShareYoY
1.41TWD+0.77%
1.40TWD+33.78%
1.05TWD—
Access this data via the Eulerpool API
Get Free API Key

Han Biomedical Stock analysis

What does Han Biomedical do? Han Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Han Biomedical stock

Free Cash Flow per Share of Han Biomedical is 1.41 TWD in 2024.

Free Cash Flow per Share of Han Biomedical changed from 1.40 TWD to 1.41 TWD, representing a 0.77% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Han Biomedical since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API
Get Free API Key

Cash Flow — Han Biomedical

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Han Biomedical